Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test.

@article{Solomon2013EffectOH,
  title={Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test.},
  author={Cristina Solomon and N Rahe-meyer and Herbert Sch{\"o}chl and Marco Ranucci and Klaus Goerlinger},
  journal={Blood transfusion = Trasfusione del sangue},
  year={2013},
  volume={11 3},
  pages={412-8}
}
BACKGROUND Point-of-care thromboelastometry (ROTEM(®)) can be used to assess coagulation in whole blood. In the ROTEM(®) FIBTEM test, cytochalasin D eliminates the contribution of platelets to the whole blood clot; hence, only the remaining elements, including fibrinogen/fibrin, red blood cells and factor XIII, contribute to clot strength. We investigated the relationships between FIBTEM maximum clot firmness (MCF), whole blood fibrinogen concentration and plasma fibrinogen concentration to… CONTINUE READING